image_1_Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea.jpg
Obstructive sleep apnea (OSA) is associated with insulin resistance (IR) and glucose intolerance. Elevated endothelin-1 (ET-1) levels have been observed in OSA patients and in mice exposed to intermittent hypoxia (IH). We examined whether pharmacological blockade of type A and type B ET-1 receptors (ETA and ETB) would ameliorate glucose intolerance and IR in mice exposed to IH. Subcutaneously implanted pumps delivered BQ-123 (ETA antagonist; 200 nmol/kg/day), BQ-788 (ETB antagonist; 200 nmol/kg/day) or vehicle (saline or propyleneglycol [PG]) for 14 days in C57BL6/J mice (10/group). During treatment, mice were exposed to IH (decreasing the FiO2 from 20.9% to 6%, 60/h) or intermittent air (IA). After IH or IA exposure, insulin (0.5 IU/kg) or glucose (1 mg/kg) was injected intraperitoneally and plasma glucose determined after injection and area under glucose curve (AUC) was calculated. Fourteen-day IH increased fasting glucose levels (122 ± 7 vs. 157 ± 8 mg/dL, PG: 118 ± 6 vs. 139 ± 8; both p < 0.05) and impaired glucose tolerance (AUCglucose: 19,249 ± 1105 vs. 29,124 ± 1444, PG AUCglucose: 18,066 ± 947 vs. 25,135 ± 797; both p < 0.05) in vehicle-treated animals. IH-induced impairments in glucose tolerance were partially ameliorated with BQ-788 treatment (AUCglucose: 21,969 ± 662; p < 0.05). Fourteen-day IH also induced IR (AUCglucose: 7185 ± 401 vs. 8699 ± 401; p < 0.05). Treatment with BQ-788 decreased IR under IA (AUCglucose: 5281 ± 401, p < 0.05) and reduced worsening of IR with IH (AUCglucose: 7302 ± 401, p < 0.05). There was no effect of BQ-123 on IH-induced impairments in glucose tolerance or IR. Our results suggest that ET-1 plays a role in IH-induced impairments in glucose homeostasis.
History
References
- https://doi.org//10.1513/pats.200709-155MG
- https://doi.org//10.1001/archinte.162.8.893
- https://doi.org//10.1164/rccm.201101-0130OC
- https://doi.org//10.1001/jama.2012.3418
- https://doi.org//10.1161/CIRCULATIONAHA.109.901801
- https://doi.org//10.1164/rccm.200911-1746OC
- https://doi.org//10.1056/NEJMoa043104
- https://doi.org//10.1016/j.atherosclerosis.2011.08.021
- https://doi.org//10.5665/sleep/31.8.1071
- https://doi.org//10.1371/journal.pmed.1000132
- https://doi.org//10.5665/sleep/31.8.1079
- https://doi.org//10.1093/aje/kwh261
- https://doi.org//10.1164/ajrccm.165.5.2104087
- https://doi.org//10.1164/rccm.200504-637OC
- https://doi.org//10.1152/ajpregu.00258.2012
- https://doi.org//10.3389/fneur.2012.00051
- https://doi.org//10.1164/rccm.200610-1527OC
- https://doi.org//10.1007/s00421-012-2452-3
- https://doi.org//10.1113/jphysiol.2003.048173
- https://doi.org//10.1016/j.freeradbiomed.2008.11.026
- https://doi.org//10.1113/jphysiol.2007.143586
- https://doi.org//10.1152/japplphysiol.91523.2008
- https://doi.org//10.1016/j.ecl.2013.05.001
- https://doi.org//10.5935/abc.20130179
- https://doi.org//10.1016/j.amjhyper.2006.05.021
- https://doi.org//10.1016/j.peptides.2005.02.012
- https://doi.org//10.1161/01.HYP.37.2.511
- https://doi.org//10.1097/00004872-199917010-00010
- https://doi.org//10.3109/10623329709079869
- https://doi.org//10.5114/aoms.2011.26615
- https://doi.org//10.1016/j.resp.2010.08.021
- https://doi.org//10.1152/japplphysiol.00529.2011
- https://doi.org//10.1016/j.metabol.2003.12.002
- https://doi.org//10.1007/BF00403325
- https://doi.org//10.1016/S0026-0495(03)00098-2
- https://doi.org//10.1016/0024-3205(91)90611-E
- https://doi.org//10.1172/JCI11753
- https://doi.org//10.1016/S0026-0495(98)90071-3
- https://doi.org//10.2337/db10-1281
- https://doi.org//10.2174/157339906777950642
- https://doi.org//10.2337/diabetes.52.8.1904
- https://doi.org//10.1006/bbrc.1994.1985
- https://doi.org//10.1046/j.1365-201X.1997.00212.x
- https://doi.org//10.1016/0026-0495(92)90273-D
- https://doi.org//10.1210/jc.2009-1506
- https://doi.org//10.1097/00004872-199816090-00009
- https://doi.org//10.1038/ijo.2008.212
- https://doi.org//10.2337/dc06-1978
- https://doi.org//10.1042/CS103S430S
- https://doi.org//10.1016/j.metabol.2004.12.019
- https://doi.org//10.1152/jappl.2001.91.6.2758
- https://doi.org//10.1007/BF00280883
- https://doi.org//10.1038/oby.2011.240
- https://doi.org//10.1007/978-0-387-75434-5_4
- https://doi.org//10.2337/diacare.23.9.1395
- https://doi.org//10.1152/ajpheart.91477.2007
- https://doi.org//10.1093/toxsci/kfi284
- https://doi.org//10.2337/db07-0893
- https://doi.org//10.1016/j.phrs.2004.05.009
- https://doi.org//10.1007/s11154-012-9231-7
- https://doi.org//10.1073/pnas.90.20.9266
- https://doi.org//10.2337/db17-0186
- https://doi.org//10.2337/db08-0457
- https://doi.org//10.1152/ajpendo.90760.2008
- https://doi.org//10.1016/j.bcp.2012.03.020
- https://doi.org//10.1097/FJC.0b013e31826f32c1
- https://doi.org//10.1152/jappl.2001.91.5.2407
- https://doi.org//10.1161/01.HYP.31.3.766
- https://doi.org//10.1097/00005344-199707000-00006
- https://doi.org//10.1161/01.HYP.30.6.1578
- https://doi.org//10.1161/01.HYP.30.1.29
- https://doi.org//10.1046/j.1365-2125.2000.00171.x
- https://doi.org//10.1046/j.1523-1755.2000.00315.x
- https://doi.org//10.1007/s00441-010-0936-1
- https://doi.org//10.1067/mtc.2002.121973
- https://doi.org//10.5339/gcsp.2014.29
- https://doi.org//10.1177/1753944714541511
- https://doi.org//10.1046/j.1523-1755.1998.00987.x
- https://doi.org//10.5665/sleep.3040
- https://doi.org//10.1007/s00125-005-1680-z